Many studies have shown that CD53 is increased in obese and inflammatory tissues, and regulating its expression may be an effective treatment for obesity with complications (Nair et al., 2005; Zhao et al., 2020). This evidence concerns the gene CD53 and obesity due to melanocortin 4 receptor deficiency.